New Vernon Capital Holdings Ii LLC Fulgent Genetics, Inc. Transaction History

New Vernon Capital Holdings Ii LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$29.39 - $36.27 $1,645 - $2,031	56 Added 1.23%	4,619 $144,000
Q4 2022 Feb 14, 2023	BUY	$29.23 - $40.28 $85,351 - $117,617	2,920 Added 177.72%	4,563 $135,000
Q3 2022 Nov 14, 2022	SELL	$37.92 - $63.74 $6,598 - $11,090	-174 Reduced 9.58%	1,643 $63,000
Q2 2022 Aug 15, 2022	BUY	$47.98 - $62.75 $87,179 - $114,016	1,817 New	1,817 $99,000

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of New Vernon Capital Holdings Ii LLC, based on Form 13F filings with the SEC.

Stay updated on New Vernon Capital Holdings Ii LLC with notifications on news.